Domenico Lepore

Rome, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 42 publications

Three-Year Outcomes of Intravitreal Aflibercept versus Laser Therapy for Retinopathy of Prematurity: Interim Analysis of the Efficacy and Safety Outcomes in the FIREFLEYE next Trial.

Three-Year Outcomes of Intravitreal Aflibercept versus Laser Therapy for Retinopathy of Prematurity: Interim Analysis of the Efficacy and Safety Outcomes in the FIREFLEYE next Trial.

Journal: Neonatology

Published: June 13, 2025

Cord red blood cell transfusions for severe retinopathy in preterm neonates in Italy: a multicenter randomized controlled trial.

Cord red blood cell transfusions for severe retinopathy in preterm neonates in Italy: a multicenter randomized controlled trial.

Journal: EClinicalMedicine

Published: May 28, 2025

RWC Update: Management of Persistent Peripheral Avascular Retina in Retinopathy of Prematurity Survivors; Giant Macular Hole Leading to a Total Retinal Detachment; Proliferative Sickle Cell Retinopathy: Intraoperative Fluorescein Angiography Guided Management.

RWC Update: Management of Persistent Peripheral Avascular Retina in Retinopathy of Prematurity Survivors; Giant Macular Hole Leading to a Total Retinal Detachment; Proliferative Sickle Cell Retinopathy: Intraoperative Fluorescein Angiography Guided Management.

Journal: Ophthalmic surgery, lasers & imaging retina

Published: May 12, 2025

Plain-language commentary: 2-year findings from the FIREFLEYE next study looking at how well aflibercept injected into affected eyes in babies with retinopathy of prematurity works and how safe it is compared with laser treatment.

Plain-language commentary: 2-year findings from the FIREFLEYE next study looking at how well aflibercept injected into affected eyes in babies with retinopathy of prematurity works and how safe it is compared with laser treatment.

Journal: Therapeutic advances in ophthalmology

Published: December 12, 2024

Intravitreal Aflibercept vs Laser Therapy for Retinopathy of Prematurity: Two-Year Efficacy and Safety Outcomes in the Nonrandomized Controlled Trial FIREFLEYE next.

Intravitreal Aflibercept vs Laser Therapy for Retinopathy of Prematurity: Two-Year Efficacy and Safety Outcomes in the Nonrandomized Controlled Trial FIREFLEYE next.

Journal: JAMA network open

Published: April 30, 2024

Taser-Related Ocular Injuries: A Review of the Literature and Medico-Legal Implications.

Taser-Related Ocular Injuries: A Review of the Literature and Medico-Legal Implications.

Journal: Seminars in ophthalmology

Published: March 19, 2024

Cord blood transfusions in extremely low gestational age neonates to reduce severe retinopathy of prematurity: results of a prespecified interim analysis of the randomized BORN trial.

Cord blood transfusions in extremely low gestational age neonates to reduce severe retinopathy of prematurity: results of a prespecified interim analysis of the randomized BORN trial.

Journal: Italian journal of pediatrics

Published: March 19, 2024

Correction: Systemic exposure to aflibercept after intravitreal injection in premature neonates with retinopathy of prematurity: results from the FIREFLEYE randomized phase 3 study.

Correction: Systemic exposure to aflibercept after intravitreal injection in premature neonates with retinopathy of prematurity: results from the FIREFLEYE randomized phase 3 study.

Journal: Eye (London, England)

Published: February 09, 2024

Functional outcomes and quality of life after AcrySof IQ Vivity intraocular lens implantation in a real-world study.

Functional outcomes and quality of life after AcrySof IQ Vivity intraocular lens implantation in a real-world study.

Journal: Scientific reports

Published: January 24, 2024

Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): five-year outcomes of a randomised trial.

Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): five-year outcomes of a randomised trial.

Journal: EClinicalMedicine

Published: December 05, 2023

Systemic exposure to aflibercept after intravitreal injection in premature neonates with retinopathy of prematurity: results from the FIREFLEYE randomized phase 3 study.

Systemic exposure to aflibercept after intravitreal injection in premature neonates with retinopathy of prematurity: results from the FIREFLEYE randomized phase 3 study.

Journal: Eye (London, England)

Published: October 16, 2023

Avascular Peripheral Retina in Infants.

Avascular Peripheral Retina in Infants.

Journal: Turkish journal of ophthalmology

Published: February 27, 2023

Showing 1-12 of 42

Last Updated: 09/26/2026